Home › Diffuse Large B-Cell Lymphoma › Florida › Orlando
Diffuse Large B-Cell Lymphoma clinical trials in Orlando, FL
5 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
RecruitingPhase 2/3
- Clermont Oncology Center ( Site 0174), Clermont · 24 mi away
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
RecruitingPhase 3
- Orlando Health Cancer Institute ( Site 0169), Ocoee · 10 mi away
- Clermont Oncology Center ( Site 0182), Clermont · 24 mi away
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
RecruitingPhase 2
- Orlando Health Cancer Institute, Orlando
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
RecruitingPhase 2
- Advent Health Cancer Institute, Orlando
- Orlando Health Cancer Institute, Orlando
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RecruitingPhase 3
- AdventHealth, Orlando
Diffuse Large B-Cell Lymphoma trials in other cities
- New York City, NY21 studies
- Baldwin Park, CA19 studies
- Chicago, IL18 studies
- Houston, TX17 studies
- Los Angeles, CA17 studies
- Milwaukee, WI16 studies
- Boston, MA16 studies
- Philadelphia, PA15 studies
- Portland, OR15 studies
- Durham, NC14 studies
- Nashville, TN14 studies
- Dallas, TX13 studies
Other studies in Orlando
- Non-Small Cell Lung Cancer44 studies
- Metastatic Cancer29 studies
- Obesity29 studies
- Cancer (all types)25 studies
- Alzheimer's Disease25 studies
- Overweight25 studies
- Type 2 Diabetes24 studies
- Breast Cancer23 studies
- Ulcerative Colitis23 studies
- Ovarian Cancer22 studies
- Lung Cancer21 studies
- Major Depressive Disorder19 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.